Imrecoxib

艾瑞昔布

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameImrecoxib
Drug Alias Name恒扬BAP-909
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsAcute PainOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsOsteoarthritis
Approved Indications in ChinaOsteoarthritis
Original Approved Country/TerritoryMainland China
Original Approved Date2011/05/20
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Active IndicationsOsteoarthritis
Inactive IndicationsAcute PainOsteoarthritis, Knee

Other Information

ATC CodeM01AH
Related LinksDrugBank